[1] The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2021: an updated summary. Biomed Environ Sci, 2022; 35, 573−603.
[2] The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2022: an updated summary. Biomed Environ Sci, 2023; 36, 669−701.
[3] National Center for Cardiovascular Diseases. The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Report on cardiovascular health and diseases in China 2023: an updated summary. Biomed Environ Sci, 2024; 37, 949−92.
[4] Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet, 2018; 391, 1706-17.
[5] Klompmaker JO, Laden F, James P, et al. Long-term exposure to summer specific humidity and cardiovascular disease hospitalizations in the US Medicare population. Environ Int, 2023; 179, 108182. doi:  10.1016/j.envint.2023.108182
[6] Fang W, Li Z, Gao J, et al. The joint and interaction effect of high temperature and humidity on mortality in China. Environ Int, 2023; 171, 107669. doi:  10.1016/j.envint.2022.107669
[7] Zheng CY, Wu JM, Tang HS, et al. Relationship of ambient humidity with cardiovascular diseases: A prospective study of 24,510 adults in a general population. Biomed Environ Sci, 2024; 37, 1352−61.
[8] Zhong C, Lan M, Tu C, et al. Nanoplastics in the human respiratory system. Am J Respir Crit Care Med, 2024; 210, 1059−61. doi:  10.1164/rccm.202403-0605RL
[9] Prattichizzo F, Ceriello A, Pellegrini V, et al. Micro-nanoplastics and cardiovascular diseases: evidence and perspectives. Eur Heart J, 2024; 45, 4099−110. doi:  10.1093/eurheartj/ehae552
[10] Zhu Y, Liang R, Pu L, et al. Relevance of household chemical usage to respiratory diseases in older adults in China. Biomed Environ Sci, 2024; 37, 1373−84.
[11] Nasr Z, Schoeps VA, Ziaei A, et al. Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry, 2023; 94, 518−25. doi:  10.1136/jnnp-2022-330713
[12] Li J, Liang F, Liu F, et al. Genetic risk modifies the effect of long-term fine particulate matter exposure on coronary artery disease. Environ Int, 2022; 170, 107624. doi:  10.1016/j.envint.2022.107624
[13] Moll M, Sordillo JE, Ghosh AJ, et al. Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol, 2023; 152, 1423−32. doi:  10.1016/j.jaci.2023.08.002
[14] Yang Z, Lin Z, Ning X, et al. The genetic association between CDKN1A and heart failure: Genome-wide exploration of m6A-SNPs and Mendelian randomization. Biomed Environ Sci, 2024; 37, 1397−408.
[15] Miller PG, Qiao D, Rojas-Quintero J, et al. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood, 2022; 139, 357−68. doi:  10.1182/blood.2021013531
[16] Zhao K, Shen X, Liu H, et al. Somatic and germline variants and coronary heart disease in a chinese population. JAMA Cardiol, 2024; 9, 233−42. doi:  10.1001/jamacardio.2023.5095
[17] Ding E, Deng F, Fang J, et al. Exposome-wide ranking to uncover environmental chemicals associated with dyslipidemia: A panel study in healthy older Chinese adults from the BAPE Study. Environ Health Perspect, 2024; 132, 97005. doi:  10.1289/EHP13864